Indeed, in resected patients, TERT mutation is among the strongest predictors of tumor recurrence, together with tumor dimensions (i.e. pathological stage) and the occurrence of portal microvascular invasion, which should always be described separately from the classic MVI in the histopathological report. The gene discussed is TERT; the disease is neoplasm.